Compounds > 1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid
Page last updated: 2024-12-10
1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid
Description
You're asking about **1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid**. This is a chemical compound that has shown significant potential for use in research, particularly in the field of **drug discovery and development**.
Here's a breakdown of why this molecule is important:
**1. Chemical Structure:**
* **Boronic acid:** The key functional group in this compound is the boronic acid (B(OH)₂) moiety. This group is known for its ability to bind to various functional groups, like hydroxyl groups (OH), amines (NH₂) and other biomolecules.
* **Pyrrolidine ring:** This compound also contains two pyrrolidine rings, which are 5-membered cyclic amines. These rings are common in medicinal chemistry and can be tailored to interact with specific biological targets.
**2. Potential Applications in Drug Discovery:**
* **Target validation:** 1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid can be used to investigate the binding affinity of potential drug candidates to various proteins, enzymes, and receptors. This information is crucial in identifying the most promising targets for new drugs.
* **Drug development:** This compound can serve as a scaffold or building block for the synthesis of novel drug candidates. The boronic acid moiety can be further modified to enhance its properties, such as solubility, stability, and target specificity.
* **Chemical probes:** The specific binding properties of this compound make it a useful chemical probe to study the function of certain biological targets. It can help researchers understand how these targets work at a molecular level.
**3. Importance in Research:**
* **Drug discovery for various diseases:** The versatile nature of this molecule makes it potentially useful for research on diseases like cancer, neurodegenerative disorders, and infectious diseases.
* **Understanding biological pathways:** The ability to bind to and modify specific proteins can help researchers understand complex biological processes.
* **Innovation in drug development:** The potential for further chemical modifications of this compound could lead to the development of new and more effective drugs.
**Important Note:** It's essential to understand that while 1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid shows promise in research, it is not yet a commercially available drug. Ongoing research is needed to further explore its potential benefits and safety profile.
1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid: a dipeptidyl peptidase IV inhibitor; RN given refers to compound with no isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 3035635 |
SCHEMBL ID | 4417766 |
MeSH ID | M0221015 |
Synonyms (10)
Synonym |
[1-(pyrrolidine-2-carbonyl)pyrrolidin-2-yl]boronic acid |
boronic acid, (1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinyl)- |
1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid |
(1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinyl)boronic acid |
133745-65-0 |
SCHEMBL4417766 |
DTXSID20928257 |
(1-prolylpyrrolidin-2-yl)boronic acid |
(1-(pyrrolidine-2-carbonyl)pyrrolidin-2-yl)boronic acid |
PD038588 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.66 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |